Eric Daar, MD, Infectious Disease, Torrance, CA, Harbor-UCLA Medical Center

EricS.DaarMD

Infectious Disease Torrance, CA

Professor of Medicine, UCLA-David Geffen School of Medicine

Dr. Daar is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Daar's full profile

Already have an account?

  • Office

    1124 W Carson St., CDCRC 205
    Division of HIV Medicine, Harbor-UCLA Medical Center
    Torrance, CA 90502
    Phone(310) 222-5101
    Fax(310) 320-5463
  • Is this information wrong?

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Infectious Disease, 1988 - 1991
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1985 - 1988
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2021
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Other

Authored Content

  • Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1November 2018

Press Mentions

  • Scientists Employ New Genetic Technology in Developing COVID-19 Vaccines
    Scientists Employ New Genetic Technology in Developing COVID-19 VaccinesNovember 19, 2020 15:39
  • Candidates for COVID-19 Vaccine and Therapeutic Begin SoCal Trials
    Candidates for COVID-19 Vaccine and Therapeutic Begin SoCal TrialsOctober 22, 2020 13:31
  • UCLA to Begin Phase 3 COVID-19 Vaccine Trial in L.A
    UCLA to Begin Phase 3 COVID-19 Vaccine Trial in L.AAugust 27, 2020 11:11
  • Join now to see all

Grant Support

  • Clinical Trial: A Phase IIIB, Randomized, Trial Of Open-Label Efavirenz Or AtazaNational Center For Research Resources2010
  • Clinical Trial: A Phase III Comparative Study Of Three Non-Nucleoside Reverse TRNational Center For Research Resources2010
  • California Neuroaids Tissue Network (CNTN)National Center For Research Resources2010
  • A Longitudinal Study Of Cerebral And Neurocognitive FunctionNational Center For Research Resources2009–2010
  • Long-Term Metabolic Assessments In Subjects Treated With Emtricitabine/TenofoNational Center For Research Resources2007–2010
  • California Neuro AIDS Tissue NetworkNational Center For Research Resources2004–2010
  • A Phase II/III Randomized, Double-Blind, Placebo-Controlled TriaNational Center For Research Resources2009
  • Clinical Trial: A Phase II/III Randomized, Double-Blind, Placebo-Controlled TriaNational Center For Research Resources2008
  • Acute HIV Infection And Early Disease Research Program (AIEDRP)National Center For Research Resources2005–2008
  • California Neuro - AIDS Tissue NetworkNational Center For Research Resources2004–2008
  • Pathogenesis Of Primary HIV InfectionNational Center For Research Resources1998–2008
  • The Setpoint Study - A Randomized Study Of The Effect Of Immediate TreatmentNational Center For Research Resources2007
  • A Phase III, Randomized, Open-Label, Comparison Of Lopinavir/Ritonavir PLUS ENational Center For Research Resources2005–2007
  • Phase III, Randomized, Open-Label, Comparison Of LopinNational Center For Research Resources2004

Hospital Affiliations